A review of late-stage CNS drug candidates for the treatment of obesity. [electronic resource]
Producer: 20130624Description: 107-17 p. digitalISSN:- 1476-5497
- Anti-Obesity Agents -- administration & dosage
- Bupropion -- pharmacology
- Central Nervous System Stimulants -- pharmacology
- Drug Administration Schedule
- Drug Approval
- Drug Combinations
- Drug Design
- Drugs, Investigational
- Female
- Guidelines as Topic
- Humans
- Male
- Naltrexone -- pharmacology
- Obesity -- drug therapy
- Patient Selection
- Phentermine -- pharmacology
- Receptor, Serotonin, 5-HT2C -- drug effects
- Risk Factors
- Risk Reduction Behavior
- United Kingdom -- epidemiology
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.